Cryosite Ltd (CTE) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.361x

Based on the latest financial reports, Cryosite Ltd (CTE) has a cash flow conversion efficiency ratio of 0.361x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.30 Million ≈ $921.96K USD) by net assets (AU$3.61 Million ≈ $2.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CTE net asset quality index to measure how much of total assets are equity-financed.

Cryosite Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Cryosite Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Cryosite Ltd to evaluate the quality of earnings relative to operating cash generation.

Cryosite Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cryosite Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SG Choongbang Co Ltd
KO:001380
-0.005x
Archer Materials Ltd
AU:AXE
-0.246x
Canlan Ice Sports Corp.
TO:ICE
0.085x
RS GROUP PLC
LSE:RS1
0.087x
HCL Infosystems Limited
NSE:HCL-INSYS
0.049x
Globalink Investment Inc
NASDAQ:GLLI
-0.010x
Korea Electronic Certification Authority Inc
KQ:041460
0.036x
Kworld Computer Co Ltd
TWO:3287
0.030x

Annual Cash Flow Conversion Efficiency for Cryosite Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Cryosite Ltd from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Cryosite Ltd stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$2.39 Million
≈ $1.69 Million
AU$2.06 Million
≈ $1.46 Million
0.864x -54.36%
2024-06-30 AU$1.45 Million
≈ $1.03 Million
AU$2.74 Million
≈ $1.94 Million
1.893x +274.03%
2023-06-30 AU$2.78 Million
≈ $1.97 Million
AU$1.41 Million
≈ $996.25K
0.506x -62.25%
2022-06-30 AU$1.86 Million
≈ $1.32 Million
AU$2.49 Million
≈ $1.77 Million
1.341x +130.27%
2021-06-30 AU$819.23K
≈ $579.65K
AU$476.96K
≈ $337.48K
0.582x -93.10%
2020-06-30 AU$154.88K
≈ $109.58K
AU$1.31 Million
≈ $924.35K
8.435x +2135.42%
2019-06-30 AU$-1.72 Million
≈ $-1.21 Million
AU$-647.54K
≈ $-458.17K
0.377x +379.99%
2018-06-30 AU$1.94 Million
≈ $1.38 Million
AU$-261.91K
≈ $-185.32K
-0.135x -126.08%
2017-06-30 AU$3.15 Million
≈ $2.23 Million
AU$1.63 Million
≈ $1.15 Million
0.517x +267.77%
2016-06-30 AU$3.38 Million
≈ $2.39 Million
AU$474.61K
≈ $335.82K
0.140x -64.86%
2015-06-30 AU$3.54 Million
≈ $2.51 Million
AU$1.42 Million
≈ $1.00 Million
0.400x +54.74%
2014-06-30 AU$6.14 Million
≈ $4.34 Million
AU$1.58 Million
≈ $1.12 Million
0.258x -16.57%
2013-06-30 AU$6.26 Million
≈ $4.43 Million
AU$1.94 Million
≈ $1.37 Million
0.310x -9.74%
2012-06-30 AU$5.48 Million
≈ $3.88 Million
AU$1.88 Million
≈ $1.33 Million
0.343x +13.39%
2011-06-30 AU$4.69 Million
≈ $3.32 Million
AU$1.42 Million
≈ $1.00 Million
0.303x +34.76%
2010-06-30 AU$4.35 Million
≈ $3.08 Million
AU$977.66K
≈ $691.75K
0.225x +37.27%
2009-06-30 AU$4.34 Million
≈ $3.07 Million
AU$709.86K
≈ $502.27K
0.164x -20.44%
2008-06-30 AU$4.32 Million
≈ $3.06 Million
AU$888.27K
≈ $628.51K
0.206x +10.08%
2007-06-30 AU$3.74 Million
≈ $2.64 Million
AU$697.65K
≈ $493.63K
0.187x +358.76%
2006-06-30 AU$2.81 Million
≈ $1.99 Million
AU$-203.02K
≈ $-143.65K
-0.072x +10.55%
2005-06-30 AU$2.48 Million
≈ $1.75 Million
AU$-199.90K
≈ $-141.44K
-0.081x +66.81%
2004-06-30 AU$3.04 Million
≈ $2.15 Million
AU$-738.72K
≈ $-522.69K
-0.243x +20.88%
2002-06-30 AU$3.89 Million
≈ $2.75 Million
AU$-1.20 Million
≈ $-845.61K
-0.307x -27.31%
2001-06-30 AU$3.87 Million
≈ $2.74 Million
AU$-933.52K
≈ $-660.52K
-0.241x --

About Cryosite Ltd

AU:CTE Australia Diagnostics & Research
Market Cap
$41.44 Million
AU$58.57 Million AUD
Market Cap Rank
#22613 Global
#825 in Australia
Share Price
AU$1.20
Change (1 day)
+0.00%
52-Week Range
AU$0.66 - AU$1.30
All Time High
AU$1.30
About

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more